All lobbying filings

Bracewell LLP

Bracewell LLP filed a Q3 report for Aquestive Therapeutics on October 14, 2026, reporting $60,000 in lobbying income.

Lobbying for Aquestive Therapeutics · pharmaceutical company

As filed: BRACEWELL LLP for AQUESTIVE THERAPEUTICS.

All filings by Bracewell LLP · Everything Aquestive Therapeutics has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 14, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Consumer Issues/Safety/Products

CPSC issues related to packaging

Issues related to therapeutics

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem